Institut De Recherches Internationales Servier

This study tested a drug called calaspargase pegol in adults aged 22 and older with a specific type of leukemia (Philadelphia-negative ALL). The goal was to find the right dose and check for side effects. The trial was stopped early, but researchers were looking at how the drug w…

This study used special PET scans to track an experimental drug (S095012) in people with advanced solid tumors that had stopped responding to standard treatments. Only 3 participants were enrolled before the study was ended early. The goal was to see where the drug went in the bo…